MSF Field Research > 1 Published Research and Commentary > Trypanosomiasis/Sleeping Sickness > Browsing MSF

Browsing "Trypanosomiasis/Sleeping Sickness" by Issue Date

Jump to a point in the index:
Or type in a year:

Sort by: In order: Results/Page Authors/Record:

Showing results 1 to 20 of 38
Issue DateTitleAuthor(s)
Dec-2012 Human african trypanosomiasis in the democratic republic of the congo: a looming emergency?Hasker, Epco; Lutumba, Pascal; Chappuis, François; Kande, Victor; Potet, Julien; De Weggheleire, Anja; Kambo, Charles; Depoortere, Evelyn; Pécoul, Bernard; Boelaert, Marleen; Institute of Tropical Medicine, Antwerp, Belgium.
29-Nov-2012 In-hospital safety in field conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. B. Gambiense Sleeping SicknessSchmid, Caecilia; Kuemmerle, Andrea; Blum, Johannes; Ghabri, Salah; Kande, Victor; Mutombo, Wilfried; Ilunga, Medard; Lumpungu, Ismael; Mutanda, Sylvain; Nganzobo, Pathou; Tete, Digas; Mubwa, Nono; Kisala, Mays; Blesson, Severine; Mordt, Olaf Valverde; Department of Medicines Research, Swiss Tropical and Public Health Institute, Basel, Switzerland.
9-Nov-2012 Nifurtimox-Eflornithine Combination Therapy for Second-stage Gambiense Human African Trypanosomiasis: Médecins Sans Frontières experience in the Democratic Republic of the CongoAlirol, Emilie; Schrumpf, David; Amici Heradi, Josué; Riedel, Andrea; de Patoul, Catherine; Quere, Michel; Chappuis, François; Division of International and Humanitarian Medicine, University Hospitals of Geneva, Switzerland. emilie.alirol@hcuge.ch
5-Jun-2012 Early prediction of treatment efficacy in Second-Stage Gambiense Human African TrypanosomiasisPriotto, Gerardo; Chappuis, François; Bastard, Mathieu; Flevaud, Laurence; Etard, Jean-François; Epicentre, Paris, France. gpriotto@neuf.fr
Jul-2011 Accuracy of five algorithms to diagnose gambiense human African trypanosomiasis.Checchi, Francesco; Chappuis, François; Karunakara, Unni; Priotto, Gerardo; Chandramohan, Daniel; London School of Hygiene and Tropical Medicine, United Kingdom. Francesco.checchi@lshtm.ac.uk
26-May-2011 Challenges of controlling sleeping sickness in areas of violent conflict: experience in the Democratic Republic of Congo.Tong, Jacqueline; Valverde, Olaf; Mahoudeau, Claude; Yun, Oliver; Chappuis, François; Médecins Sans Frontières, Rue de Lausanne 78, 1211 Geneva, Switzerland. jacquitong@yahoo.co.uk.
4-Apr-2011 Sleeping sicknessMalvy, D; Chappuis, F; Travel Clinics and Division of Tropical Medicine and Imported Diseases, Department of Internal Medicine and Tropical Diseases, University Hospital Centre, Bordeaux, France; Universite de Bordeaux, Faculty of Medicine, INSERM U897 and Centre Rene-Labusquiere (Tropical Medicine Branch), Bordeaux, France; Division of International and Humanitarian Medicine, Geneva University Hospital, Switzerland; Medecins Sans Frontieres, Operational Centre, Geneva, Switzerland
21-Dec-2010 The Unknown Risk of Vertical Transmission in Sleeping Sickness--a Literature ReviewLindner, Andreas K; Priotto, Gerardo; London School of Hygiene & Tropical Medicine, United Kingdom; Epicentre, France
25-May-2010 NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness.Yun, Oliver; Priotto, Gerardo; Tong, Jacqueline; Flevaud, Laurence; Chappuis, François; Médecins Sans Frontières/Doctors Without Borders, New York, New York, USA; Epicentre, Paris, France; Médecins Sans Frontières, Geneva, Switzerland; Médecins Sans Frontières, Barcelona, Spain; Geneva University Hospitals, Geneva, Switzerland
1-Feb-2010 Human African trypanosomiasis in areas without surveillance.Chappuis, Francois; Lima, Maria Angeles; Flevaud, Laurence; Ritmeijer, Koert; Médecins Sans Frontières, Geneva, Switzerland; Geneva University Hospitals, Geneva, Switzerland; Médecins sans Frontières, Barcelona, Spain; Médecins sans Frontières, Amsterdam, the Netherlands
14-Oct-2009 Human African trypanosomiasisBrun, Reto; Blum, Johannes; Chappuis, Francois; Burri, Christian; Swiss Tropical Institute, Basel, Switzerland; Geneva University Hospitals, University of Geneva, Switzerland; Médecins Sans Frontières, Geneva, Switzerland
7-Jul-2009 Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans FrontièresYun, Oliver; Lima, M Angeles; Ellman, Tom; Chambi, Wilma; Castillo, Sandra; Flevaud, Laurence; Roddy, Paul; Parreño, Fernando; Albajar Viñas, Pedro; Palma, Pedro Pablo; Médecins Sans Frontières/Doctors Without Borders, New York, NY, USA; Médecins Sans Frontières, Operational Center Barcelona-Athens (OCBA), Barcelona, Spain; Médecins Sans Frontières/Médicos Sin Fronteras, La Paz, Bolivia; Laboratory of Parasitological Diseases, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil
4-Jul-2009 Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trialPriotto, Gerardo; Kasparian, Serena; Mutombo, Wilfried; Ngouama, Daniel; Ghorashian, Sara; Arnold, Ute; Ghabri, Salah; Baudin, Elisabeth; Buard, Vincent; Kazadi-Kyanza, Serge; Ilunga, Médard; Mutangala, Willy; Pohlig, Gabriele; Schmid, Caecilia; Karunakara, Unni; Torreele, Els; Kande, Victor; Epicentre, Paris, France;Ministry of Health, Republic of the Congo;Médecins Sans Frontières, Holland and Belgium;Swiss Tropical Institute, Basel, Switzerland;Drugs for Neglected Diseases Initiative, Geneva, Switzerland
Feb-2009 [Médecins Sans frontières (MSF) and sleeping sickness control. From bush to international health space]d'Alessandro, E; CNRS UMR 6578 et Fondation MSF. eugeniealessandro@hotmail.com
21-Oct-2008 Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.Balasegaram, Manica; Young, H; Chappuis, Francois; Priotto, Gerardo; Raguenaud, Marie-Eve; Checchi, Francesco; Médecins Sans Frontières-United Kingdom, 67-74 Saffron Hill, London EC1N 8QX, UK.
5-Mar-2008 Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort studyPriotto, Gerardo; Pinoges, Loretxu; Badi Fursa, Isaac; Burke, Barbara; Nicolay, Nathalie; Grillet, Guillaume; Hewison, Cathy; Balasegaram, Manica; Epicentre, Paris, France; Médecins Sans Frontières, Paris, France
8-Feb-2008 Estimates of the duration of the early and late stage of gambiense sleeping sickness.Checchi, Francesco; Filipe, João A N; Haydon, Daniel T; Chandramohan, D; Chappuis, Francois; Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E7HT, UK. francesco.checchi@lshtm.ac.uk
Feb-2008 Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola.Robays, J; Raguenaud, Marie-Eve; Josenando, T; Boelaert, M; Institute of Tropical Medicine, Antwerp, Belgium. Medecins Sans Frontieres Belgium. National Sleeping Sickness control program of Angola
1-Dec-2007 Melarsoprol-Free Drug Combinations for Second-Stage Gambian Sleeping Sickness: The Way to Go.Chappuis, Francois; Travel and Migration Medicine Unit, Geneva University Hospital, and Medecins Sans Frontieres, Swiss Section, 1202 Geneva, Switzerland. francois.chappuis@hcuge.ch
1-Dec-2007 Nifurtimox-eflornithine Combination Therapy for Second-Stage Trypanosoma Brucei Gambiense Sleeping Sickness: A Randomized Clinical Trial in Congo.Priotto, Gerardo; Kasparian, Serena; Ngouama, Daniel; Ghorashian, Sara; Arnold, Ute; Ghabri, Salah; Karunakara, Unni; Epicentre, Paris, France. gpriotto@epicentre.msf.org
Showing results 1 to 20 of 38

 

OR Logo Powered by Open Repository | Cookies

My MSF

MSF logo MSF Field Research

Apr 23, 2014